Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 4/20 | 0.47 |
| ▸ | PDGFRA | P16234 | 4/20 | 0.47 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.46 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.46 |
| ▸ | TOP2A | P11388 | 1/20 | 0.45 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.43 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.40 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.39 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13759492 | 0.92 | CYP2A6 (0.50) | PDGFRBPDGFRAPIK3CDPIK3CAPIK3CB | |
| SCHEMBL13759482 | 0.87 | BIRC5 (0.48) | PDGFRBPDGFRAPIK3CDPIK3CAPIK3CB | |
| SCHEMBL13759476 | 0.86 | PIK3CD (0.47) | PDGFRBPDGFRAPIK3CDPIK3CAPIK3CB | |
| SCHEMBL12435754 | 0.86 | CYP1A1 (0.44) | ESR1ESR2KDM4E | |
| SCHEMBL13759478 | 0.86 | PDGFRB (0.45) | PDGFRBPDGFRAPIK3CDPIK3CAPIK3CB | |
| SCHEMBL13759495 | 0.84 | BIRC5 (0.48) | PDGFRBPDGFRAPIK3CDPIK3CAPIK3CB | |
| SCHEMBL13004545 | 0.84 | PDGFRB (0.56) | PDGFRBPDGFRAPIK3CDPIK3CAPIK3CB | |
| SCHEMBL13759489 | 0.84 | PDGFRB (0.47) | PDGFRBPDGFRAPIK3CDPIK3CAPIK3CB | |
| SCHEMBL13759516 | 0.83 | PDGFRB (0.45) | PDGFRBPDGFRAPIK3CDPIK3CAPIK3CB | |
| SCHEMBL29662082 | 0.82 | BIRC5 (0.57) | PDGFRBPDGFRAPIK3CDPIK3CAPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210359214-A1 | ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-11-18 | — | — | US | disclosed |
| US-8367220-B2 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-05 | — | — | US | disclosed |
| US-8367219-B2 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-05 | — | — | US | disclosed |
| US-8367220-B2 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-05 | — | — | US | disclosed |
| US-8367219-B2 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-05 | — | — | US | disclosed |
| US-20090166670-A1 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-07-02 | — | — | US | disclosed |
| US-20090166670-A1 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-07-02 | — | — | US | disclosed |
| EP-2055702-A1 | Anthracene-based compound and organic light emitting device employing the same | Samsung Electronics Co., Ltd. (KR) | 2009-05-06 | — | — | EP | disclosed |
| US-20090108746-A1 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-04-30 | — | — | US | disclosed |
| US-20090108746-A1 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090166670-A1 | Anthracene-based compound and organic light emitting device employing the same | CCNL2, CRY2, ATXN2L | PDGFRB 4497/4885PDGFRA 4542/4885PIK3CD 3696/4885 |
| US-20090108746-A1 | Anthracene-based compound and organic light emitting device employing the same | CCNL2, CRY2, ATXN2L | PDGFRB 4497/4885PDGFRA 4542/4885PIK3CD 3696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.